Skip to main content
. 2019 Nov 8;9:1223. doi: 10.3389/fonc.2019.01223

Figure 2.

Figure 2

Maintaining low circulating concentrations of IL-6 and IL-8 is associated with improved overall survival. (A) Overall survival of stage IV melanoma patients based on the plasma concentration of IL-6 or IL-8. (B) Overall survival based on the plasma concentration of IL-6 and IL-8. Analysis of overall survival of patients whose levels of IL-6 (C) or IL-8 (D) remained low or remained high during the follow-up period.